Browse By Region

Browse By Category
Recent News
By Category: Public Health
Suspect powder at Italy ministry sparks false alarm
(Chicago Tribune) Seven people were taken to hospital for checks after a suspect package at Italy’s labor ministry containing powder raised fears of possible anthrax contamination, but the parcel was found to be harmless. A ministry spokesman confirmed it was a false alarm after officials inspected the package at the offices in central Rome. Activists Read More »
- December 6, 2012
- | Filed under Europe, North America, Agents & Toxins, International, and Public Health
National Institute of Health Awards Contract to Support Use of iBio’s Proprietary Technology for Improved Anthrax Vaccine
(Sacramento Bee) In October 2012, iBio announced issuance of a U.S. patent covering compositions of matter and methods of producing anthrax vaccines, an expansion of the Company’s portfolio of assets relevant to bio-defense and infectious disease product applications. Data previously published in peer-reviewed scientific journals demonstrated the effectiveness of the iBioLaunch platform for development and Read More »
- December 6, 2012
- | Filed under North America, Agents & Toxins, Public Health, and Research
Predicting, preventing, and controlling pandemics: Making the case for a strategic action plan
(EurekAlert) About 60% of infectious diseases are caused by viruses, bacteria and other pathogens that make the jump to humans from other species. This includes some of the most devastating disease outbreaks of the past 30 years, including HIV/AIDS, Ebola, and SARS. Despite the huge and rising toll of such diseases, many gaps remain in Read More »
- December 5, 2012
- | Filed under North America, Countermeasures, Policy & Initiatives, and Public Health
Recombinant Production of Carrier Proteins
(Genetic Engineering News) Within the rapidly growing vaccine space, conjugate vaccines—polysaccharide antigens covalently linked to carrier proteins—have been shown to be effective against several bacterial pathogens. Conjugate vaccines use carrier proteins to increase the immunogenicity of antigens (e.g., peptides, oligosaccharides, polysaccharides) and other haptens. These antigens are poor immunogens unless conjugated to proteins. The role Read More »
- December 4, 2012
- | Filed under North America, Agents & Toxins, Public Health, and Research
Yellow fever outbreak kills 164 in Sudan’s Darfur: WHO
(Chicago Tribune) Yellow fever has killed 164 people over the last three months in Sudan’s Darfur, the World Health Organization (WHO) said on Monday, an arid region the size of Spain where fighting and banditry makes access particularly difficult. Healthcare is provided almost entirely by aid agencies in parts of Darfur, where rebels took up Read More »
- December 4, 2012
- | Filed under Africa, North America, Agents & Toxins, International, and Public Health